Live Breaking News & Updates on Urogen Pharma

Stay updated with breaking news from Urogen pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UroGen Pharma (NASDAQ:URGN) PT Lowered to $32.00 at Oppenheimer

UroGen Pharma (NASDAQ:URGN – Free Report) had its price target cut by Oppenheimer from $34.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have an outperform rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $54.00 target price on shares of UroGen Pharma […] ....

Urogen Pharma , Mark Schoenberg , Urogen Pharma Ltd , Connor Clark Lunn Investment Management Ltd , China Universal Asset Management Co , Allspring Global Investments Holdings , Jump Financial , Securities Exchange Commission , Free Report , Gen Pharma Trading Down , Gen Pharma , Get Free Report , Exchange Commission , Global Investments Holdings , Universal Asset Management , Financial Markets , Connor Clark , Lunn Investment Management , Gen Pharma Ltd , Urogen Pharma Daily ,

UroGen Pharma First Quarter 2024 Earnings: Misses Expectations

UroGen Pharma First Quarter 2024 Earnings: Misses Expectations
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Urogen Pharma , Gen Pharma Revenues , Earnings Miss ,

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2024 Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Paul Choi , William Huang , Elizabeth Barrett , Matt Kaplan , Vincent Perrone , Mark Schoenberg , Don Kim , Tara Bancroft , Jeff Bova , Raghuram Selvaraju , Liz Barrett , Leland Gershell , Urogen Pharma Ltd , Ladenburg Thalmann , Hc Wainwright Co , Goldman Sachs , Urogen Pharma , Call Transcript May , Urogen Pharma First Quarter , First Quarter , Business Update Conference , Chief Executive Officer , Chief Medical Officer , Chief Commercial Officer ,

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Urogen Pharma , Liz Barrett , Urogen Rtgel , Drug Administration , American Urological Association , Urogen Pharma Ltd , Company Investigational New Drug , Chief Executive Officer , Recent Business Highlights , New Drug Application , Investigational New Drug , Prepaid Forward Obligation , Long Term Debt , Pharmakon Advisors , Cash Equivalents , Operating Expense , Webcast Information , Upper Tract Urothelial Cancer , Prescribing Information , Patient Information , Utilizing Urogen , Private Securities Litigation Reform Act , Risk Factors , Annual Report ,

URGN Stock Earnings: UroGen Pharma Misses EPS, Misses Revenue for Q1 2024

URGN Stock Earnings: UroGen Pharma Misses EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Urogen Pharma , Market News , Stock Advice , Urogen Pharma Misses , Misses Revenue ,